HIV coinfection with tuberculosis laboratory findings

Revision as of 18:01, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

HIV coinfection with tuberculosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating HIV coinfection with tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

HIV coinfection with tuberculosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV coinfection with tuberculosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV coinfection with tuberculosis laboratory findings

CDC on HIV coinfection with tuberculosis laboratory findings

HIV coinfection with tuberculosis laboratory findings in the news

Blogs on HIV coinfection with tuberculosis laboratory findings

Directions to Hospitals Treating HIV coinfection with tuberculosis

Risk calculators and risk factors for HIV coinfection with tuberculosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

A new rapid diagnostic test for TB disease, the Xpert MTB/RIF assay (which is not currently approved by the US Food and Drug Administration for use in the US), is expected to reduce patient and health service diagnostic delays, decentralize the diagnosis of MDR TB and HIV-associated TB, and accelerate patient access to appropriate care. Evidence suggests that use of the test might double the number of HIV-associated TB cases diagnosed in areas with high rates of TB and HIV.

Rapid HIV tests, using finger-prick or oral specimens, can also be used. Results are available in about 20 minutes. The rapid HIV test kits cost about $10. Although the rapid HIV test kits cost more than standard lab assays, they have been shown to be cost-effective. Also they increase patients’ acceptance to HIV testing. Another option is to collect oral swab specimens and use standard lab assays.

To read more about other lab test, click here.

References

Template:WH Template:WS